Calendar

pharmadog

Week of Feb 2, 2026

Feb 4, 2026approval188d agoATROPINE SULFATE — FDA approvalATROPINE SULFATE

Sponsor: ACCORD HLTHCARE. Form: SOLUTION. Route: INTRAVENOUS

full page →ATROPINE SULFATE →fda approvals ↗

Feb 4, 2026approval188d agoCARBOPLATIN — FDA approvalOncotelic Therapeutics, Inc.

Sponsor: QILU PHARM HAINAN. Form: INJECTABLE. Route: INTRAVENOUS

full page →fda approvals ↗

Feb 4, 2026recall188d agoHaleon US Holdings LLC recall (Cls III)

parodontax (cetylpyridinium chloride)ACTIVE GUM HEALTH, Mouthwash, Mint. Net Wt 16.9 FL OZ (500 mL), Distributed by Haleon, Warren, NJ 07059. NDC 0135-0651-02 — Reason: Labeling: Incorrect or Missing Lot and/or Exp Date: Potential for missing or illegible lot and expiration date coding on the bottles. — Status: Ongoing

full page →fda recalls ↗

Feb 4, 2026recall188d agoBaxter Healthcare Corporation recall (Cls II)Baxter Healthcare Corp

Sterile Water for Irrigation, 250 mL, Single-Dose Plastic Bottle, Rx Only, Baxter Healthcare Corporation Deerfield, IL 60015 NDC: 0338-0004-02. — Reason: Presence of particulate matter: plastic particles from the bottle rim were observed floating into the solution — Status: Ongoing

full page →fda recalls ↗

Feb 4, 2026recall188d agoNOVADOZ PHARMACEUTICALS LLC recall (Cls III)Novadoz Pharmaceuticals LLC

Glycopyrrolate Oral Solution, 1 mg/5 mL, 16 oz. (473 mL), Rx only, Manufactured by: MSN Pharmaceuticals Inc., Piscataway, NJ 08854, Distributed by: Novadoz Pharmaceuticals LLC, Piscataway, NJ 08854, NDC 72205-070-72 — Reason: Failed Impurities/Degradation Specifications — Status: Ongoing

full page →fda recalls ↗

Feb 4, 2026recall188d agoGreenstone Llc recall (Cls II)Greenstone LLC

methylprednisolone tablets, USP Dosepak, 4 mg, 1 Blister Card per Carton containing 21 Tablets, Rx only, Distributed by: Greenstone LLC, Peapack, NJ 07977. NDC 59762-4440-2 — Reason: Labeling: Not Elsewhere Classified. Incorrect orientation of the blister foil applied to the blister cavities, which results in incorrect dosing information when following the directions on the foil. — Status: Ongoing

full page →fda recalls ↗

Feb 4, 2026recall188d agoSato Pharmaceutical Co., Ltd recall (Cls II)TAKEDA PHARMACEUTICAL CO LTD

INON ACE Antacid tablets (magnesium aluminosilicate, magnesium hydroxide and simethicone), 75-count bottle, Manufactured by: Sato Pharmaceutical Co., Ltd., NDC 49873-402-01 — Reason: Failed Disintegration Specifications: above the time expected. — Status: Ongoing

full page →fda recalls ↗

Feb 5, 2026approval187d agoAZTREONAM — FDA approvalAZTREONAM

Sponsor: HIKMA. Form: INJECTABLE. Route: INJECTION

full page →AZTREONAM →fda approvals ↗

Feb 5, 2026approval187d agoFLUOROURACIL — FDA approvalEfudex

Sponsor: SAGENT PHARMS INC. Form: INJECTABLE. Route: INJECTION

full page →Efudex →fda approvals ↗

Feb 5, 2026approval187d agoFLUOROURACIL — FDA approvalEfudex

Sponsor: SAGENT PHARMS INC. Form: INJECTABLE. Route: INJECTION

full page →Efudex →fda approvals ↗

Feb 5, 2026approval187d agoFLUOROURACIL — FDA approvalExtrovis AG

Sponsor: KINDOS. Form: INJECTABLE. Route: INJECTION

full page →fda approvals ↗

Feb 5, 2026approval187d agoNICOTINE POLACRILEX — FDA approvalPL Developments Copiague LLC

Sponsor: P AND L. Form: GUM, CHEWING. Route: BUCCAL

full page →fda approvals ↗

Feb 5, 2026approval187d agoNYSTATIN — FDA approvalActavis Mid Atlantic LLC

Sponsor: STERANCO HLTHCARE. Form: SUSPENSION. Route: ORAL

full page →fda approvals ↗

Feb 5, 2026approval187d agoFLUOROURACIL — FDA approvalExtrovis AG

Sponsor: KINDOS. Form: INJECTABLE. Route: INJECTION

full page →fda approvals ↗

Feb 5, 2026approval187d agoBUMETANIDE — FDA approvalBUMETANIDE

Sponsor: MSN. Form: TABLET. Route: ORAL

full page →BUMETANIDE →fda approvals ↗

Feb 5, 2026approval187d agoFLUOROURACIL — FDA approvalEfudex

Sponsor: ACCORD HLTHCARE. Form: INJECTABLE. Route: INJECTION

full page →Efudex →fda approvals ↗

Feb 5, 2026approval187d agoFLUOROURACIL — FDA approvalExtrovis AG

Sponsor: EUGIA PHARMA SPECLTS. Form: INJECTABLE. Route: INJECTION

full page →fda approvals ↗

Feb 5, 2026approval187d agoFLUOROURACIL — FDA approvalExtrovis AG

Sponsor: EUGIA PHARMA SPECLTS. Form: INJECTABLE. Route: INJECTION

full page →fda approvals ↗

Feb 5, 2026approval187d agoPRUCALOPRIDE SUCCINATE — FDA approvalSpecGx LLC

Sponsor: TEVA PHARMS INC. Form: TABLET. Route: ORAL

full page →fda approvals ↗

Feb 5, 2026approval187d agoCARBIDOPA, LEVODOPA AND ENTACAPONE (CARBIDOPA) — FDA approvalcarbidopa

Sponsor: ALEMBIC. Form: TABLET. Route: ORAL

full page →carbidopa →fda approvals ↗

Feb 5, 2026approval187d agoMYQORZO (AFICAMTEN) — FDA approvalaficamten

Sponsor: CYTOKINETICS. Form: TABLET. Route: ORAL

full page →aficamten →fda approvals ↗

Feb 5, 2026approval187d agoFLUOROURACIL — FDA approvalEfudex

Sponsor: ACCORD HLTHCARE. Form: INJECTABLE. Route: INJECTION

full page →Efudex →fda approvals ↗

Feb 5, 2026approval187d agoHYDROCORTISONE SODIUM SUCCINATE — FDA approvalHYDROCORTISONE SODIUM SUCCINATE

Sponsor: APOTEX. Form: INJECTABLE. Route: INJECTION

full page →HYDROCORTISONE SODIUM SUCCINATE →fda approvals ↗

Feb 5, 2026approval187d agoFLUOROURACIL — FDA approvalExtrovis AG

Sponsor: NOVAST LABS. Form: INJECTABLE. Route: INJECTION

full page →fda approvals ↗

Feb 5, 2026approval187d agoFLUOROURACIL — FDA approvalEfudex

Sponsor: ALEMBIC. Form: INJECTABLE. Route: INJECTION

full page →Efudex →fda approvals ↗

Feb 5, 2026approval187d agoFLUOROURACIL — FDA approvalExtrovis AG

Sponsor: NOVAST LABS. Form: INJECTABLE. Route: INJECTION

full page →fda approvals ↗

Feb 5, 2026approval187d agoZOLEDRONIC ACID — FDA approvalZOLEDRONIC ACID

Sponsor: GLAND. Form: INJECTABLE. Route: INTRAVENOUS

full page →ZOLEDRONIC ACID →fda approvals ↗

Feb 5, 2026approval187d agoFLUOROURACIL — FDA approvalEfudex

Sponsor: ALEMBIC. Form: INJECTABLE. Route: INJECTION

full page →Efudex →fda approvals ↗

Feb 5, 2026approval187d agoFLUOROURACIL — FDA approvalEfudex

Sponsor: FRESENIUS KABI USA. Form: INJECTABLE. Route: INJECTION

full page →Efudex →fda approvals ↗

Feb 5, 2026approval187d agoFLUOROURACIL — FDA approvalEfudex

Sponsor: FRESENIUS KABI USA. Form: INJECTABLE. Route: INJECTION

full page →Efudex →fda approvals ↗

Feb 6, 2026approval186d agoANAGRELIDE HYDROCHLORIDE — FDA approvalTakeda Pharmaceuticals USA Inc

Sponsor: BARR LABS. Form: CAPSULE. Route: ORAL

full page →fda approvals ↗

Feb 6, 2026approval186d agoOLANZAPINE AND FLUOXETINE HYDROCHLORIDE (FLUOXETINE HYDROCHLORIDE) — FDA approvalFLUOXETINE HYDROCHLORIDE

Sponsor: EPIC PHARMA LLC. Form: CAPSULE. Route: ORAL

full page →FLUOXETINE HYDROCHLORIDE →fda approvals ↗

Feb 6, 2026approval186d agoGLYCOPYRROLATE — FDA approvalFresenius Kabi USA LLC

Sponsor: PH HEALTH. Form: TABLET. Route: ORAL

full page →fda approvals ↗

Feb 6, 2026approval186d agoIDARUBICIN HYDROCHLORIDE — FDA approvalIDARUBICIN HYDROCHLORIDE

Sponsor: PFIZER. Form: SOLUTION. Route: INTRAVENOUS

full page →IDARUBICIN HYDROCHLORIDE →fda approvals ↗

Feb 6, 2026approval186d agoPRAVASTATIN SODIUM — FDA approvalSenores Pharmaceuticals Inc

Sponsor: SENORES PHARMS. Form: TABLET. Route: ORAL

full page →fda approvals ↗

Feb 6, 2026approval186d agoTICAGRELOR — FDA approvalTICAGRELOR

Sponsor: MANKIND PHARMA. Form: TABLET. Route: ORAL

full page →TICAGRELOR →fda approvals ↗

Feb 6, 2026approval186d agoNOREPINEPHRINE BITARTRATE IN 0.9% SODIUM CHLORIDE (NOREPINEPHRINE BITARTRATE) — FDA approvalNOREPINEPHRINE BITARTRATE

Sponsor: BAXTER HLTHCARE CORP. Form: SOLUTION. Route: INTRAVENOUS

full page →NOREPINEPHRINE BITARTRATE →fda approvals ↗

Feb 6, 2026approval186d agoDOXYCYCLINE HYCLATE — FDA approvalDOXYCYCLINE HYCLATE

Sponsor: STRIDES PHARMA INTL. Form: TABLET. Route: ORAL

full page →DOXYCYCLINE HYCLATE →fda approvals ↗

Feb 6, 2026approval186d agoDOXYCYCLINE HYCLATE — FDA approvalDOXYCYCLINE HYCLATE

Sponsor: STRIDES PHARMA INTL. Form: TABLET. Route: ORAL

full page →DOXYCYCLINE HYCLATE →fda approvals ↗

Week of Feb 9, 2026

Feb 9, 2026approval183d agoREGLAN (METOCLOPRAMIDE HYDROCHLORIDE) — FDA approvalANI PHARMACEUTICALS INC

Sponsor: ANI PHARMS. Form: TABLET. Route: ORAL

full page →fda approvals ↗

Feb 9, 2026approval

← prev

page 1 of 20

Week of Feb 2, 2026

Week of Feb 9, 2026